Breaking News Instant updates and real-time market news.

PG

Procter & Gamble

$78.19

-0.23 (-0.29%)

, TEVA

Teva

$17.91

0.065 (0.36%)

05:23
04/19/18
04/19
05:23
04/19/18
05:23

Procter & Gamble acquires Consumer Health business of Merck KGaA for EUR 3.4B

Procter & Gamble (PG) announced it has signed an agreement to acquire the Consumer Health business of Merck KGaA, Darmstadt, Germany, for a purchase price of approximately EUR 3.4B. This acquisition enables P&G to expand its successful consumer health care business by adding a fast-growing portfolio of differentiated, physician-supported brands across a broad geographic footprint. It also provides P&G with strong health care commercial and supply capabilities, deep technical mastery and proven consumer health care leadership that will complement P&G's existing consumer Health Care capabilities and brands such as Vicks, Metamucil, Pepto-Bismol, Crest and Oral-B. &G's acquisition of the Consumer Health business of Merck KGaA, Darmstadt, Germany, will improve P&G's OTC geographic scale, brand portfolio and category footprint in the vast majority of the world's top 15 OTC markets. These brands provide great solutions in relieving muscle, joint and back pain, colds and headaches, as well as supporting physical activity and mobility, many of which are treatment areas not currently addressed in P&G's portfolio. The acquisition of the Consumer Health business of Merck KGaA, Darmstadt, Germany, replaces and improves upon the highly successful PGT Healthcare joint venture P&G had with Teva Pharmaceutical (TEVA), which will be terminated July 1, 2018, pending regulatory approvals. P&G is targeting to close this deal during the 2018/19 fiscal year, subject to customary closing conditions and regulatory clearances.

PG

Procter & Gamble

$78.19

-0.23 (-0.29%)

TEVA

Teva

$17.91

0.065 (0.36%)

  • 19

    Apr

  • 27

    Apr

  • 18

    May

  • 05

    Jun

  • 16

    Jun

PG Procter & Gamble
$78.19

-0.23 (-0.29%)

04/04/18
LEHM
04/04/18
NO CHANGE
Target $84
LEHM
Equal Weight
Now not right time to get positive on P&G shares, says Barclays
Barclays analyst Lauren Lieberman says that while a challenging fiscal Q3 for Procter & Gamble (PG) is well telegraphed, she's now more cautious on the company's sales over the next two quarters given recent commentary from Walmart (WMT) around lower inventory levels. The analyst notes that Walmart accounted for 16% of P&G's sales in fiscal 2017. Despite the recent pullback in the shares, now is not the time to get become more constructive on Procter & Gamble, Lieberman tells investors in a research note. The analyst keeps an Equal Weight rating on the name with an $84 price target.
02/28/18
02/28/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Dell Technologies (DVMT) initiated with a Buy at Deutsche Bank and an Outperform at Wells Fargo. 2. Procter & Gamble (PG) initiated with a Sell at Berenberg. 3. Surmodics (SRDX) initiated with a Buy at Needham. 4. Fortress Biotech (FBIO) initiated with a Buy at B. Riley FBR. 5. Madrigal Pharmaceuticals (MDGL) initiated with an Outperform at Cowen. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/28/18
BREN
02/28/18
INITIATION
Target $78.5
BREN
Sell
Procter & Gamble initiated with a Sell at Berenberg
Berenberg analyst James Targett initiated Procter & Gamble with a Sell and $78.50 price target.
01/16/18
01/16/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Qualcomm (QCOM) upgraded to Buy from Neutral at Nomura Instinet with analyst Romit Shah saying with Broadcom's (AVGO) hostile takeover attempt now analogous to a "gun to the head," Qualcomm management is likely to more aggressively focus on driving shareholder value in order to remain a standalone franchise. 2. Twitter (TWTR) upgraded to Buy from Sell at Aegis with analyst Victor Anthony saying he believes 2018 will be an inflection point in owned and operated advertising for Twitter and he sees a return to double-digit growth in that area in 2019. 3. Procter & Gamble (PG) upgraded to Neutral from Sell at Goldman Sachs with analyst Jason English saying he no longer sees enough downside to estimates to drive material underperformance for the stock. 4. Northrop Grumman (NOC) and Curtiss-Wright (CW) were upgraded to Outperform from Market Perform at Wells Fargo. 5. Ciena (CIEN) was upgraded to Buy from Neutral at Goldman Sachs, while Adtran (ADTN) was upgraded to Neutral from Sell. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
TEVA Teva
$17.91

0.065 (0.36%)

03/26/18
RBCM
03/26/18
NO CHANGE
Target $16
RBCM
Sector Perform
RBC Capital concerned with 'overly ambitious' consensus assumptions for Teva
RBC Capital analyst Randall Stanicky lowered his price target on Teva to $16 from $18, saying that his own model contrasts with "overly optimistic" consensus regarding the P&L assumptions in the company's Branded segment. Specifically, the analyst is concerned with the rising generic competition for Teva's Copaxone as well as fremanezumab, which he expects to miss the June 16 PDUFA "given Celltrion's outstanding Warning Letter" while lowering his peak sales projections by $200M to $1B. Stanicky keeps his Sector Perform rating on Teva, adding that the multi-year turnaround investment thesis on the stock is not supported at this point.
03/20/18
JEFF
03/20/18
INITIATION
Target $19
JEFF
Hold
Teva resumed with a Hold at Jefferies
Jefferies analyst David Steinberg resumed coverage of Teva Pharmaceutical with a Hold rating and $19 price target. The analyst sees "headwinds on multiple fronts" and believes the positive outlook for Austedo and fremanezumab is priced in with the shares trading at 10 times 2020 consensus EBITDA.
02/21/18
DBAB
02/21/18
NO CHANGE
Target $20
DBAB
Hold
Deutsche sees rifamycin as possible long-term threat to Valeant
The outlook for Valeant Pharmaceuticals' (VRX) Xifaxan, which represents 13% of the company's revenue, improved last year following safety issues for competitor Viberzi and delays for generic challenger Teva (TEVA), Deutsche Bank analyst Gregg Gilbert tells investors in a research note. More recently, the analyst notes, questions have been raised as to whether Cosmo's rifamycin could pose a threat to Xifaxan, either in the near term from off-label prescribing for irritable bowel syndrome with diarrhea, or longer term if eventually approved for IBS-D. After due diligence, Gilbert believes rifamycin could potentially be a longer-term threat to Xifaxan if it works for IBS-D, but he does not see "material risk" from off-label use in the interim. His model continues to assume mid-single digit Xifaxan sales growth for several years and a generic cliff in 2025. The analyst keeps a Hold rating on Valeant with a $20 price target.
02/13/18
WELS
02/13/18
NO CHANGE
WELS
Teva generic comes earlier than expected, says Wells Fargo
Wells Fargo analyst David Maris says Momenta Pharmaceuticals' (MNTA) generic approval of Teva Pharmaceutical's (TEVA) Copaxone came earlier than expected. As recently as the Q4 conference call on February 8, Teva management expected that another generic Copaxone approval would not come until April 2018, Maris tells investors in a research note. The analyst's forecasts assume a continued erosion of Copaxone sales, with sales of $700M in Q1, $500M sales in Q2 and $400M in Q3 and Q4. Maris keeps an Underperform rating on Teva.

TODAY'S FREE FLY STORIES

AMZN

Amazon.com

$1,944.93

18.66 (0.97%)

, DLB

Dolby

$68.99

0.5 (0.73%)

14:01
09/20/18
09/20
14:01
09/20/18
14:01
Periodicals
Amazon unveils all-new Echo Show with complete redesign »

According to a live blog…

AMZN

Amazon.com

$1,944.93

18.66 (0.97%)

DLB

Dolby

$68.99

0.5 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

FB

Facebook

$165.20

2.14 (1.31%)

, TWTR

Twitter

$29.80

0.27 (0.91%)

14:00
09/20/18
09/20
14:00
09/20/18
14:00
Periodicals
Facebook, Twitter, Alphabet to leave technology sector of S&P 500, WSJ says »

Investors are in for a…

FB

Facebook

$165.20

2.14 (1.31%)

TWTR

Twitter

$29.80

0.27 (0.91%)

GOOG

Alphabet

$1,185.00

14.03 (1.20%)

GOOGL

Alphabet Class A

$1,189.17

14.51 (1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 26

    Sep

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 03

    Mar

ACAD

Acadia

$18.77

3.66 (24.22%)

13:59
09/20/18
09/20
13:59
09/20/18
13:59
Recommendations
Acadia analyst commentary  »

FDA conclusion on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

GLW

Corning

$36.24

0.98 (2.78%)

13:57
09/20/18
09/20
13:57
09/20/18
13:57
Recommendations
Corning analyst commentary  »

Corning price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYK

Stryker

$173.03

-0.56 (-0.32%)

13:57
09/20/18
09/20
13:57
09/20/18
13:57
Hot Stocks
Stryker to showcase Tritanium In-Growth Technology in AR experience »

Stryker's Spine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

AMZN

Amazon.com

$1,946.29

20.02 (1.04%)

13:57
09/20/18
09/20
13:57
09/20/18
13:57
Periodicals
Amazon introduces Alexa doorbell API »

According to a live blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

FB

Facebook

$165.29

2.23 (1.37%)

, TWTR

Twitter

$29.81

0.28 (0.95%)

13:56
09/20/18
09/20
13:56
09/20/18
13:56
Periodicals
Facebook, Twitter, Alphabet to leave technology sector of S&P 500 »

Investors are in for a…

FB

Facebook

$165.29

2.23 (1.37%)

TWTR

Twitter

$29.81

0.28 (0.95%)

GOOG

Alphabet

$1,186.13

15.16 (1.29%)

GOOGL

Alphabet Class A

$1,189.54

14.88 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 26

    Sep

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 03

    Mar

TRCO

Tribune Media

$37.90

-0.07 (-0.18%)

, NXST

Nexstar

$81.35

1.1 (1.37%)

13:55
09/20/18
09/20
13:55
09/20/18
13:55
Periodicals
Tribune Media sales talks moving quickly, Dealreporter says »

Tribune Media's…

TRCO

Tribune Media

$37.90

-0.07 (-0.18%)

NXST

Nexstar

$81.35

1.1 (1.37%)

TGNA

Tegna

$12.02

0.09 (0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 08

    Nov

HRS

Harris

$161.08

-4.41 (-2.66%)

13:55
09/20/18
09/20
13:55
09/20/18
13:55
Hot Stocks
Harris receives orders for 1,540 two-channel handheld radios from U.S. Army »

Harris Corporation has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,947.40

21.13 (1.10%)

13:54
09/20/18
09/20
13:54
09/20/18
13:54
Periodicals
Amazon announces Ring Stick Up Cam, will cost $180 »

According to a live blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

PAGS

PagSeguro Digital

$29.03

0.61 (2.15%)

13:51
09/20/18
09/20
13:51
09/20/18
13:51
Conference/Events
PagSeguro Digital management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,946.57

20.3 (1.05%)

13:51
09/20/18
09/20
13:51
09/20/18
13:51
Periodicals
Amazon announces Alexa Guard, Echo Guard »

According to a live blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

REPYY

Repsol

$0.00

(0.00%)

13:49
09/20/18
09/20
13:49
09/20/18
13:49
Hot Stocks
CaixaBank to sell existing shareholding in Repsol »

CaixaBank S.A. announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,946.26

19.99 (1.04%)

13:48
09/20/18
09/20
13:48
09/20/18
13:48
Periodicals
Amazon introduces Echo Wall Clock »

According to a live blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AMZN

Amazon.com

$1,945.51

19.24 (1.00%)

13:45
09/20/18
09/20
13:45
09/20/18
13:45
Periodicals
Amazon unveils Alexa-enabled microwave »

According to a live blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AMZN

Amazon.com

$1,946.00

19.73 (1.02%)

13:42
09/20/18
09/20
13:42
09/20/18
13:42
Periodicals
Amazon unveils Alexa Connect Kit for developers »

According to a live blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

QQQ

Invesco QQQ Trust

$184.72

2.01 (1.10%)

13:40
09/20/18
09/20
13:40
09/20/18
13:40
Options
Large put spread in Invesco QQQ as a hedge is adjusted »

Large put spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,944.99

18.72 (0.97%)

13:39
09/20/18
09/20
13:39
09/20/18
13:39
Periodicals
Amazon unveils Alexa Hunches feature »

According to a live blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AMZN

Amazon.com

$1,945.00

18.73 (0.97%)

13:36
09/20/18
09/20
13:36
09/20/18
13:36
Periodicals
Amazon introduces Amazon Smart Plug »

According to a live blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AMZN

Amazon.com

$1,944.64

18.37 (0.95%)

13:34
09/20/18
09/20
13:34
09/20/18
13:34
Periodicals
Amazon highlights focus on 'frustration-free setup' of smart devices »

According to a live blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AMZN

Amazon.com

$1,944.00

17.73 (0.92%)

13:30
09/20/18
09/20
13:30
09/20/18
13:30
Periodicals
Amazon unveils new Echo Plus with fabric design and temperature sensor »

According to a live blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AMZN

Amazon.com

$1,944.72

18.45 (0.96%)

13:26
09/20/18
09/20
13:26
09/20/18
13:26
Periodicals
Amazon unveils Echo Link and Echo Link Amp »

According to a live blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

13:25
09/20/18
09/20
13:25
09/20/18
13:25
Conference/Events
UBS consumer goods analyst to hold an analyst/industry conference call »

Consumer Goods Analyst…

13:25
09/20/18
09/20
13:25
09/20/18
13:25
Conference/Events
Citigroup airlines analysts to hold an analyst/industry conference call »

Airlines Analysts hold an…

AMZN

Amazon.com

$1,944.75

18.48 (0.96%)

13:24
09/20/18
09/20
13:24
09/20/18
13:24
Periodicals
Amazon unveils new subwoofer Echo Sub »

Amazon devices head David…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.